Medical Director of the Regional Reference Laboratories and the Regional Assistant Medical Director of Laboratory Services for the Southern California Permanente Medical Group in Pasadena

Medical Director of the Regional Reference Laboratories and the Regional Assistant Medical Director of Laboratory Services for the Southern California Permanente Medical Group in Pasadena

SEARCH FILTERS
Time filter
Source Type

Lee E.A.,Assistant Chief of Internal Medicine at the West Los Angeles Medical Center and Co Chair of the Southern California Permanente Medical Group High Risk Drugs in the Elderly Committee in Pasadena | Gibbs N.E.,Kaiser Permanente | Martin J.,Internist at the Los Angeles Medical Center and Co Director of the Southern California Permanente Medical Group Diabetes Complete Care Program in Pasadena | Ziel F.,Kaiser Permanente | And 2 more authors.
The Permanente journal | Year: 2016

Diabetes affects more than 25% of Americans older than age 65 years. The medical care of older patients must differ from the care of their younger counterparts. Older patients are at high risk of drug toxicity. A hemoglobin A1c (HbA1c) level less than 7.0% has historically been the goal of all patients with diabetes, regardless of age. Recent research has demonstrated that using medications to achieve such tight glycemic control is not necessary and is often not safe.This article discusses the seminal research findings that strongly suggest that HbA1c goals should be relaxed in older patients. The authors then recommend an age-specific and functionally appropriate HbA1c reference range for patients receiving medications to improve glycemic control. Other interventions are suggested that should make diabetes care safer in older patients receiving hypoglycemic medications.

Loading Medical Director of the Regional Reference Laboratories and the Regional Assistant Medical Director of Laboratory Services for the Southern California Permanente Medical Group in Pasadena collaborators
Loading Medical Director of the Regional Reference Laboratories and the Regional Assistant Medical Director of Laboratory Services for the Southern California Permanente Medical Group in Pasadena collaborators